Riluzole
Indication
Amyotrophic Lateral Sclerosis form of Motor Neurone Disease (NICE TA20)
NICE TA20 - Guidance on the Use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease
Amber level 1
Brand:
Nice TA:
20
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Amber level 1
Reason for decision:
Shared care required
Supporting documents: